Oral tirzepatide has emerged as a viable weight loss option for patients seeking a non-injection alternative
This allowed us to hypothesise that semaglutide, which works through stimulation of insulin secretion from the beta cell, could potentially replace mealtime insulin administration. Read the study in full in New England Journal of Medicine .
1 2 "Dulaglutide (Trulicity): The Third Once-Weekly GLP-1 Agonist"
Recognizing these potential side effects can help you and your provider manage them effectively
Da Porto A, Casarsa V, Colussi G, Catena C, Cavarape A, Sechi L (2020) Dulaglutide reduces binge episodes in type 2 diabetic patients with binge-eating disorder: a pilot study
Last reviewed: June 7, 2026 Read article Product resources What vial size is listed for Tirzepatide